Materialise: A High-Margin Medical Business Hiding In Plain Sight

Impact · against what's priced in

MTLS faces a valuation headwind as stalled recurring revenue growth in its Software segment undermines the scalability of its subscription transition. While the Medical segment remains a strong driver and Manufacturing shows aerospace-led recovery, the software uncertainty creates a drag on the overall growth narrative.

MTLS+0.10

No priced-in read yet

In context

Strong double-digit growth in Medical and aerospace-driven margin potential in Manufacturing are partially offset by stalled recurring revenue growth in the Software segment.

Read from the article alone

• aerospace▲6%
• 3d printing
• MTLS
• additive manufacturing
• margin expansion
• medical devices
• recurring revenue
• software subscriptions

Top 1 mover · tap to explore